Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Hikma Pharmaceuticals Shares News & Articles

Market report: Melrose flies on aerospace sales while Boohoo struts its stuff

The FTSE 100 opens marginally lower at 7,304 on Thursday after the Prime Minister was boxed in by Parliament overnight. MPs from both sides blocked both a no-deal Brexit and a call for a snap election. In addition a number of stocks are trading ex-dividend today, dragging on the index. After the close last night FTSE Russell announced its quarterly index review, making three changes to the FTSE ...

Market report: Brexit, Bonmarche, Wizz Air in focus as Asda over takes Sainsbury in supermarket sales battle

Brexit headlines dominate the news agenda in an otherwise very quiet day for company news on the stock market on Tuesday. This follows politician’s failure again last night to come to any sort of consensus over the best way forward for the UK. That puts the pound under more pressure early on Tuesday with Sterling losing ground against both the euro and dollar. But UK stock markets remain ...

Hikma faces further delays in launching generic version of GlaxoSmithKline blockbuster drug

Hikma Pharmaceuticals (HIK) has been dealt another blow after US regulators said it had to conduct a further clinical study into its generic version of GlaxoSmithKline’s (GSK) Advair asthma treatment. The news has triggered a 1.8% decline in Hikma’s share price to 882p. Vectura (VEC) fell 7.2% to 75.4p as it is responsible for the dry powder technology for Hikma’s generic treatment. In ...
Showing 1 to 20 of 86